To make an appointment, please call 1-800-KARMANOS (1-800-527-6266) or request an appointment online
As a leader in cancer research, Karmanos is able to offer patients access to innovative treatments and clinical trials that are often times not available anywhere else.
To offer hope and longer life to patients with all types of cancer, Karmanos offers the latest types of therapy through our clinical trials program. Through clinical trials, we are creating new knowledge about how therapies fight cancer and provide national leadership in testing these new therapies.
We understand that cancer is a complex disease that demands complex care. We provide each patient with a dynamic, carefully constructed treatment plan focused on their specific cancer and their unique needs.
We listen to you to design a plan that provides you with respect, compassionate care and is responsive to your emotional and practical concerns.
Karmanos doctors are simply the best. Please help us honor our amazing cancer doctors by sending them a virtual thank you note. After you hit submit, we will deliver your message to your favorite doctor. It’s that simple. Have more than one favorite doctor? No worries! You can submit as many thank you messages as you would like. Family members and friends are also invited to participate.
We also welcome video messages, which can be sent to us at MarketingandCommunications@karmanos.org.
Please note that the Karmanos Cancer Institute may use some submissions for marketing or social media purposes.
If you have any questions, please contact our Marketing and Communications Department at MarketingandCommunications@karmanos.org.
*Indicates required information
The Barbara Ann Karmanos Cancer Institute has been named one of America’s 2025 Best Hospitals for Cancer Care, Mammogram Imaging, Minimally Invasi...
From a young age, music has been a big part of Sierra Watson’s life. In seventh grade, she started playing the bassoon. It became a passion of her...
MedPage Today Dipesh Uprety, M.D., FACP , medical oncologist, member of the Phase I Clinical Trials and Thoracic Oncology ...